SCN1A Gene Generalized Epilepsy with Febrile Seizures Plus Type 2 Genetic Test sale cost 4400 AED
SCN11A Gene Episodic pain syndrome type 3 familial Genetic Test sale cost 4400 AED SCN11A Gene Episodic pain syndrome type 3 familial Genetic Test Cost 5,600 د.إ Original price was: 5,600 د.إ.4,400 د.إCurrent price is: 4,400 د.إ.
MGAT2 Gene Glycosylation Disorder Type 2A Genetic Test sale cost 4400 AED MGAT2 Gene Glycosylation Disorder Type 2A Genetic Test Cost 5,600 د.إ Original price was: 5,600 د.إ.4,400 د.إCurrent price is: 4,400 د.إ.
Sale!

SCN1A Gene Generalized Epilepsy with Febrile Seizures Plus Type 2 Genetic Test Cost

Original price was: 5,600 د.إ.Current price is: 4,400 د.إ.

-21%

The SCN1A gene Generalized Epilepsy with Febrile Seizures Plus Type 2 (GEFS+2) genetic test is a specialized diagnostic tool available at DNA Labs UAE, designed to detect mutations in the SCN1A gene. This gene plays a critical role in the functioning of brain cells by coding for a subunit of the sodium channel, which is essential for the transmission of electrical signals in the nervous system. Mutations in the SCN1A gene are associated with various epilepsy syndromes, including GEFS+2, which is characterized by a spectrum of seizure types that range from mild febrile seizures to more severe forms of epilepsy.

The test is particularly important for individuals who have a family history of GEFS+2 or exhibit symptoms suggestive of this condition. By analyzing a sample of the patient’s DNA, the test can confirm the presence of mutations in the SCN1A gene, providing valuable information for diagnosis, management, and treatment planning. This can also offer insights into the risk of epilepsy in family members and the likelihood of passing the condition to offspring.

The cost of the SCN1A gene Generalized Epilepsy with Febrile Seizures Plus Type 2 genetic test at DNA Labs UAE is 4400 AED. Given the complexity of the test and the specific expertise required to interpret the results, it represents a critical investment in the accurate diagnosis and tailored management of epilepsy syndromes associated with SCN1A mutations.

Home  Sample collection service available

  • 100% accuaret Test Results
  • Ranked as Most trusted Genetic DNA Lab
  • This test is not intended for medical diagnosis or treatment
Guaranteed Safe Checkout

SCN1A Gene Generalized epilepsy with febrile seizures plus type 2 Genetic Test

Welcome to DNA Labs UAE, where we offer the SCN1A Gene Generalized epilepsy with febrile seizures plus type 2 Genetic Test. This test aims to diagnose and provide valuable information about Generalized Epilepsy with Febrile Seizures Plus (GEFS+), a genetic disorder associated with the SCN1A gene.

Test Details

The SCN1A gene is linked to GEFS+, a disorder characterized by febrile seizures that occur in childhood and may progress to other types of seizures, including generalized seizures. This disorder is inherited and can be caused by mutations in the SCN1A gene.

Our Next-Generation Sequencing (NGS) technology allows for the analysis of multiple genes simultaneously. With NGS genetic testing, we can identify mutations in the SCN1A gene and diagnose GEFS+. Additionally, this test can identify other genetic mutations associated with epilepsy or other neurological disorders.

Test Components and Price

Our SCN1A Gene Generalized epilepsy with febrile seizures plus type 2 Genetic Test is priced at 4400.0 AED.

Sample Condition

We accept blood samples, extracted DNA, or one drop of blood on an FTA card as sample conditions for this test.

Report Delivery

You can expect your test results to be delivered within 3 to 4 weeks.

Method

We utilize NGS technology for this test.

Test Type

This test is specifically designed for Neurological Disorders.

Doctor and Test Department

This test is conducted under the supervision of a Neurologist and falls under the Genetics department.

Pre Test Information

Prior to the test, it is important to provide the clinical history of the patient who will undergo the SCN1A Gene Generalized epilepsy with febrile seizures plus type 2 NGS Genetic DNA Test. Additionally, a Genetic Counselling session will be conducted to draw a pedigree chart of family members affected with GEFS+.

Conclusion

NGS genetic testing is a non-invasive procedure that involves collecting a blood or saliva sample from the patient. The collected sample will then be sent to our laboratory for analysis. Our experts will sequence and analyze the DNA for mutations in the SCN1A gene. The results of this test will not only assist physicians in determining the most suitable treatment plan for the patient but also provide valuable information for genetic counseling and family planning.

Test Name SCN1A Gene Generalized epilepsy with febrile seizures plus type 2 Genetic Test
Components
Price 4400.0 AED
Sample Condition Blood or Extracted DNA or One drop Blood on FTA Card o
Report Delivery 3 to 4 Weeks
Method NGS Technology
Test type Neurological Disorders
Doctor Neurologist
Test Department: Genetics
Pre Test Information Clinical History of Patient who is going for SCN1A Gene Generalized epilepsy with febrile seizures plus type 2 NGS Genetic DNA Test A Genetic Counselling session to draw a pedigree chart of family members affected with SCN1A Gene Generalized epilepsy with febrile seizures plus type 2
Test Details

The SCN1A gene is associated with a genetic disorder known as Generalized Epilepsy with Febrile Seizures Plus (GEFS+), which is characterized by febrile seizures that occur in childhood and can progress to other types of seizures, including generalized seizures. GEFS+ is an inherited disorder and can be caused by mutations in the SCN1A gene.

NGS (Next-Generation Sequencing) genetic testing is a type of DNA sequencing technology that allows for the analysis of multiple genes simultaneously. NGS genetic testing can be used to identify mutations in the SCN1A gene and diagnose GEFS+. It can also be used to identify other genetic mutations that may be associated with epilepsy or other neurological disorders.

NGS genetic testing is a non-invasive test that involves collecting a blood or saliva sample from the patient. The sample is then sent to a laboratory for analysis, where the DNA is sequenced and analyzed for mutations in the SCN1A gene. The results of the test can help physicians determine the most appropriate treatment plan for the patient, as well as provide valuable information for genetic counseling and family planning.

SKU: TEST-1387 Category:

Related products